Full-night versus 4h evening polysomnography in children less than 2years of age

Paul E Kahlke1, Manisha B Witmans, Tareq Alabdoulsalam

  • 1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Sleep Medicine
|December 26, 2012
PubMed

Insights

Four-hour pediatric polysomnography (PSG) is a viable alternative to full-night studies for infants and young children. This abbreviated sleep study effectively identifies sleep-disordered breathing (SDB) in children aged 24 months and younger.

Area of Science:

  • Pediatric Sleep Medicine
  • Respiratory Physiology

Background:

  • Pediatric polysomnography (PSG) is resource-intensive and burdensome for young children and families.
  • There is a need for more efficient diagnostic methods for sleep-disordered breathing (SDB) in infants and toddlers.

Purpose of the Study:

  • To evaluate the efficacy of a 4-hour abbreviated PSG as an alternative to full-night PSG in children aged 24 months and younger.
  • To determine if abbreviated PSG can accurately assess sleep-disordered breathing (SDB) and obstructive sleep apnea (OSA) in this pediatric population.

Main Methods:

  • Compared results from the first 4 hours of PSG to full-night PSG in 105 children.
  • Analyzed total, obstructive, and central apnea indices.
  • Defined SDB as an apnea-hypopnea index (AHI) >1.5 events/h and OSA as an obstructive AHI >1.5 events/h, with specific cutoffs for central apneas based on age.

Main Results:

  • All subjects but one had abnormal SDB on full-night PSG; all had REM sleep in the first 4 hours.
  • 4-hour PSG demonstrated high sensitivity for detecting total AHI, obstructive AHI, and central apnea index across age groups (⩽6 months and >6 months).
  • Agreement between 4-hour and full-night PSG was lower for individuals with lower AHI values.

Conclusions:

  • The high prevalence of SDB in this cohort suggests PSG aims to characterize type and severity, not just presence/absence.
  • The high sensitivity of 4-hour PSG supports its use in children 24 months and under, particularly those ⩽6 months.
  • Abbreviated PSG offers a potentially less burdensome and more efficient diagnostic approach for pediatric sleep disorders.
Abstract

Related Concept Videos

Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...